Cytosorbents
CTSO
#9900
Rank
A$60.29 M
Marketcap
A$0.96
Share price
-1.26%
Change (1 day)
-28.54%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$34.26 Million, an increase over its 2023 earnings that were of -A$44.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-41.03%
2024 -A$34.26 Million-22.49%
2023 -A$44.21 Million-13.52%
2022 -A$51.12 Million34.04%
2021 -A$38.14 Million182.17%
2020 -A$13.52 Million-55.97%
2019 -A$30.69 Million14.17%
2018 -A$26.88 Million95.14%
2017 -A$13.78 Million-22.32%
2016 -A$17.74 Million39.1%
2015 -A$12.75 Million-12.89%
2014 -A$14.64 Million89%
2013 -A$7.75 Million26.65%
2012 -A$6.12 Million-26.02%
2011 -A$8.27 Million-288.45%
2010 A$4.38 M-4.17%
2009 A$4.57 M-287.19%
2008 -A$2.45 Million-47.12%
2007 -A$4.63 Million41.78%
2006 -A$3.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
A$83.67 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.20 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$4.92 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA